IIPR: Q3 AFFO was $1.96 per share as life-sciences exposure expanded and leverage stayed at 2.1x

What happened

Q3 revenue was $64.9 million and diluted AFFO was $1.96 per share, while net debt to annualized adjusted EBITDA was 2.1x. IQHQ and the Alewife Park loan increased life-sciences exposure alongside the cannabis portfolio.

Confirmed

Global impact / market context

AFFO, which means cash earnings after adjustments, shows how much cash the company generates per share. Life-sciences deals make rental income less dependent on cannabis tenants, while 2.1x borrowed-money-to-profit limits financial risk before new projects.

Analyst inference

Investors compare this cash earnings per share with prior quarters and peers to judge growth, because revenue alone ignores property costs. The 2.1x debt ratio matters for funding costs and new deals, and life-sciences tenants could diversify revenue away from cannabis regulation.

Analyst inference

What to watch

1. Watch whether Q3 revenue of $64.9 million and diluted AFFO of $1.96 per share carry into the next quarterly report, showing whether cash earnings per share are stable. Confirmed
2. Company could disclose rental income and occupancy for IQHQ and Alewife Park, showing whether life-sciences exposure adds steady cash and reduces reliance on cannabis tenants. Proposed
3. Watch net debt to annualized adjusted EBITDA staying near 2.1x, because a higher ratio means more borrowed money relative to profit and could raise funding costs or limit property purchases. Analyst inference

Evidence

• Original source link unavailable